|
Market Closed -
Nasdaq
01:30:00 31/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 3.320 USD | -5.68% |
|
+4.08% | -20.19% |
Evolution of the Average Target: Galectin Therapeutics Inc.
Evolution of the Target Price: Galectin Therapeutics Inc.
Changes in Analyst Recommendations: Galectin Therapeutics Inc.
4.IEPezRVVLL-BB3HNJYckcbwcx3fxxD8PyoQFdNEq2Ng.RAuPukEtHNXzYSSGdtUTNNNaozO4nGpK-sdwE6ca6qBkMa64Yxp5hvRfOA~586d54e6f253b1d5e8d0e519d955672e
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +231.33% | |||
| +42.48% | |||||
| +24.46% | |||||
| +8.41% | |||||
| +15.87% | |||||
| +17.86% | |||||
| +35.3% | |||||
| +1.94% | |||||
| +41.27% | |||||
| +72.28% | |||||
| Average | +49.12% | |||||
| Weighted average by Cap. | +27.19% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.320USD
Average target price
11.00USD
Spread / Average Target
+231.33%
High Price Target
11.00USD
Spread / Highest target
+231.33%
Low Price Target
11.00USD
Spread / Lowest Target
+231.33%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- GALT Stock
- Consensus Galectin Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
